Table 2.
FH ALERT’s pilot initiative key results.
| Period of time: 12 weeks | Absolute values |
|---|---|
| Cholesterol examinations | 75,431 |
| Number of patients in whom examinations were performed | 60,812 |
| Patients tested twice | 7479 |
| Patients tested three times | 2679 |
| Patients tested four times | 274 |
| Patients tested five times or more | 145 |
| Alert letters, n (%) | 3512 (4.66) |
| Number of patients triggering Alert letters | 2846 |
| Distribution of alerts | |
| Category I | |
| Adults with probable suspicion | 3177 |
| Children with strong suspicion | 154 |
| Sum, n (%) | 3331 (94.85) |
| Thereof LDL C, n (%) | 838 (25.16) |
| Thereof TC, n (%) | 2493 (74.84) |
| Category II | |
| Adults with strong suspicion, n (%) | 181 (5.15) |
| Thereof LDL C, n (%) | 47 (25.97) |
| Thereof TC, n (%) | 134 (74.03) |
| Age | |
| Patients < 18 years, n (%) | 154 (4.38) |
| Patients ≥ 18 ≤ 60 years, n (%) | 3,358 (95.62) |
| Average age (total/ female/male, years) | 48/50/47 |
| Acceptance and feedback | |
| Total number of clients of MCC Weiden GmbH, n (%) | 1411 (100) |
| Clients with Opt-out, n (%) | 200 (14.17) |
| Alerted clients | |
| Clients with alert letters, n (%) | 462 (32.74) |
| Alert letters per client (total/alerted clients) | 2.49/7.60 |
| ≥ 10 alert letters (Opt-in, cum.), n (%) | 121 (26.19) |
| ≥ 5 ≤ 9 alert letters (Opt-in, cum.), n (%) | 48 (10.39) |
| ≥ 3 ≤ 4 alert letters (Opt-in, cum.), n (%) | 37 (8.01) |
| Positive reaction by caller, n (%) | 370 (69.94) |
| Negative reaction by caller, n (%) | 38 (7.18) |
| Undifferentiated reaction by caller, n (%) | 121 (22.87) |
| FH score | |
| New visitors/recurring visitors | 101/31 |
| Completed questionnaires | 88 |
| Questionnaires > 3 | 45 |
| Genetic testing | |
| Requested genetic test kits | 93 |
| Returned genetic test kits, n (%) | 26 (27.96%) |
Data describes general information, distribution of alerts, acceptance, feedback, and genetic testing.